Lantheus Holdings, Inc. (LNTH)

USD 102.13

(0.13%)

Total Liabilities Summary of Lantheus Holdings, Inc.

  • Lantheus Holdings, Inc.'s latest annual total liabilities in 2023 was 835.25 Million USD , down -4.44% from previous year.
  • Lantheus Holdings, Inc.'s latest quarterly total liabilities in 2024 Q1 was 885.79 Million USD , up 6.05% from previous quarter.
  • Lantheus Holdings, Inc. reported annual total liabilities of 874.11 Million USD in 2022, up 118.89% from previous year.
  • Lantheus Holdings, Inc. reported annual total liabilities of 399.34 Million USD in 2021, up 12.3% from previous year.
  • Lantheus Holdings, Inc. reported quarterly total liabilities of 913.14 Million USD for 2024 Q2, up 3.09% from previous quarter.
  • Lantheus Holdings, Inc. reported quarterly total liabilities of 835.25 Million USD for 2023 FY, down -4.44% from previous quarter.

Annual Total Liabilities Chart of Lantheus Holdings, Inc. (2023 - 2012)

Historical Annual Total Liabilities of Lantheus Holdings, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 835.25 Million USD -4.44%
2022 874.11 Million USD 118.89%
2021 399.34 Million USD 12.3%
2020 355.61 Million USD 22.07%
2019 291.31 Million USD -21.02%
2018 368.82 Million USD 2.29%
2017 360.56 Million USD -0.51%
2016 362.41 Million USD -15.26%
2015 427.66 Million USD -12.51%
2014 488.84 Million USD -1.61%
2013 496.82 Million USD -0.19%
2012 497.75 Million USD 0.0%

Peer Total Liabilities Comparison of Lantheus Holdings, Inc.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 11.881%
Embecta Corp. 2.03 Billion USD 58.978%
ANI Pharmaceuticals, Inc. 471.67 Million USD -77.084%
Dynavax Technologies Corporation 375.02 Million USD -122.721%
Esperion Therapeutics, Inc. 660.79 Million USD -26.403%
Pacira BioSciences, Inc. 704.25 Million USD -18.601%
PainReform Ltd. 2.69 Million USD -30938.907%
Aquestive Therapeutics, Inc. 163.9 Million USD -409.598%
Sunshine Biopharma, Inc. 6.13 Million USD -13504.42%
SCYNEXIS, Inc. 55.45 Million USD -1406.325%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -8982.226%
Cosmos Health Inc. 30.25 Million USD -2660.95%
Journey Medical Corporation 56.49 Million USD -1378.357%
Sunshine Biopharma, Inc. 6.13 Million USD -13504.42%
Safety Shot Inc 3.89 Million USD -21360.626%
Alpha Teknova, Inc. 38.55 Million USD -2066.629%
Intra-Cellular Therapies, Inc. 136.87 Million USD -510.251%
Bright Green Corporation 6.43 Million USD -12873.653%
Procaps Group, S.A. 462.06 Million USD -80.766%
Theratechnologies Inc. 98.63 Million USD -746.782%
Harrow Health, Inc. 241.75 Million USD -245.5%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -9439.253%
Biofrontera Inc. 23.13 Million USD -3509.737%
DURECT Corporation 30.4 Million USD -2647.014%
Supernus Pharmaceuticals, Inc. 487.46 Million USD -71.348%
Cronos Group Inc. 43.73 Million USD -1809.766%
OptiNose, Inc. 194.33 Million USD -329.803%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD -2.189%
Kala Pharmaceuticals, Inc. 48.44 Million USD -1624.135%
RedHill Biopharma Ltd. 20.97 Million USD -3881.562%
Organogenesis Holdings Inc. 181.36 Million USD -360.547%
Guardion Health Sciences, Inc. 3.77 Million USD -22042.824%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -1490.475%
Radius Health, Inc. 804.29 Million USD -3.85%
Universe Pharmaceuticals INC 13.75 Million USD -5972.684%
ProPhase Labs, Inc. 42.54 Million USD -1863.278%
Phibro Animal Health Corporation 725.54 Million USD -15.122%
Procaps Group S.A. 462.06 Million USD -80.766%
Alvotech 1.88 Billion USD 55.632%
TherapeuticsMD, Inc. 14.02 Million USD -5856.761%
Viatris Inc. 27.21 Billion USD 96.931%
Rockwell Medical, Inc. 30.88 Million USD -2604.673%
Aytu BioPharma, Inc. 90.37 Million USD -824.172%
SIGA Technologies, Inc. 57.97 Million USD -1340.662%
Tilray Brands, Inc. 892.11 Million USD 6.374%
Lifecore Biomedical, Inc. 219.8 Million USD -280.008%
Shineco, Inc. 47.6 Million USD -1654.68%
PetIQ, Inc. 645.22 Million USD -29.451%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -380406.305%
Incannex Healthcare Limited 5.83 Million USD -14226.878%
Neurocrine Biosciences, Inc. 1.01 Billion USD 18.064%
Alimera Sciences, Inc. 107.35 Million USD -678.04%
Silver Spike Investment Corp. 3 Million USD -27650.96%
Assertio Holdings, Inc. 148.41 Million USD -462.781%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -43954.452%
Petros Pharmaceuticals, Inc. 21.31 Million USD -3818.493%
Clever Leaves Holdings Inc. 7.02 Million USD -11788.087%
Cyclo Therapeutics, Inc. 8.49 Million USD -9737.512%
Avadel Pharmaceuticals plc 173.38 Million USD -381.73%
Hempacco Co., Inc. 18.82 Million USD -4337.568%
Talphera, Inc. 6.29 Million USD -13179.126%
Alvotech 1.88 Billion USD 55.632%
Eagle Pharmaceuticals, Inc. 172.6 Million USD -383.926%
Currenc Group, Inc. 177.67 Million USD -370.102%
Kamada Ltd. 109.96 Million USD -659.543%
Indivior PLC 1.95 Billion USD 57.194%
Evoke Pharma, Inc. 9.64 Million USD -8557.233%
Flora Growth Corp. 17.22 Million USD -4749.942%
Cyclo Therapeutics, Inc. 8.49 Million USD -9737.512%
Evolus, Inc. 209.68 Million USD -298.335%
HUTCHMED (China) Limited 536.38 Million USD -55.719%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 4.377%
Akanda Corp. 12.66 Million USD -6492.98%